Skip to main content

Table 3 Characteristics of patients according to C3435T genotypes

From: Multi-drug resistance 1 genetic polymorphism and prediction of chemotherapy response in Hodgkin's Lymphoma

Characteristics

CC genotype

N (%)

CT genotype

N (%)

TT genotype

N (%)

P-value

Age at diagnosis

    

< 30 (n = 62)

7 (46.7)

28 (45.2)

27 (50.9)

0.823

≥ 30 (n = 68)

8 (53.3)

34 (54.8)

26 (49.1)

 

Gender

    

Males (n = 71)

7 (46.7)

29 (46.8)

35 (66)

0.095

Females (n = 59)

8 (53.3)

33 (53.2)

18 (44)

 

Histology

    

NSa (n = 62)

9 (64.3)

32 (72.7)

21 (60)

0.481

MCb (n = 31)

5 (35.7)

12 (27.3)

14 (40)

 

Stage

    

Early stages (I &II) (n = 61)

7 (50)

30 (58)

24 (53.3)

0.842

Advanced stages (III & IV) (n = 50)

7 (50)

22 (42)

21 (46.7)

 

Presence of B-symptoms

    

Yes (n = 73)

9 (60)

36 (64.3)

28 (60.9)

0.920

No (n = 44)

6 (40)

20 (35.7)

18 (39.1)

 
  1. aNodular sclerosis; bMixed cellularity.